德国患有遗传性血管的儿童的流行病学和治疗:一项追溯数据库研究
Freerk Prenzel1, Susanne Abraham2, Christoph Hirche3
1Department of Pediatrics, University of Leipzig Medical Center, Leipzig, Germany.
Clinical and translational allergy
|November 25, 2023
概括
这项研究显示,德国12岁以下儿童遗传性血管 (HAE) 的患病率高于此前所认为. 目前的治疗模式显示长期预防有限,这表明需要为儿科HAE患者提供新的治疗选择.
科学领域:
- 儿科罕见疾病 儿科罕见疾病
- 遗传性疾病的流行病学.
- 儿童的药物监督工作
背景情况:
- 遗传性血管炎 (HAE) 是一种罕见的,危及生命的遗传性疾病,可引起反复出现的胀发作.
- 关于儿童群体中HAE的流行病学和治疗的数据有限.
- 这项研究解决了12岁以下儿童对HAE的知识差距.
研究的目的:
- 为了确定德国儿科HAE的发病率和流行率.
- 分析治疗模式,配方药物和涉及的医疗专业对于12岁以下儿童的HAE.
- 确定当前儿科HAE治疗环境中的潜在未满足需求.
主要方法:
- 从2016-2021年对德国IQVIA药房索赔 (LRx) 数据库的回顾性分析.
- 对HAE特异性治疗和并用药物的检查处方.
- 专注于12岁以下的儿科患者.
主要成果:
- 儿科患者 (<12岁) 的HAE患病率为2.51:100,000,12个月患病率高达1.02:100,000.
- 门诊和儿科医生是HAE治疗的主要处方者.
- 伊卡提班作为按需治疗的使用增加,而长期预防 (LTP) 率较低;止痛药的联合治疗在诊断后下降.
结论:
- 这项研究为德国儿科HAE的流行病学和治疗提供了关键的见解.
- 在幼儿中观察到的HAE患病率超过了以前对一般群体的估计.
- 低LTP率表明,儿童HAE患者的先进长期治疗策略存在重大未满足的需求.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
170
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
170
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
Gastroesophageal Reflux Disease II: Clinical Features and Management
88
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
88
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
174
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
174
Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95
Esophageal Varices-II: Clinical Features and Management
72
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
72


